It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Looking for income without a second job? Check out these innovative ways to make money without adding more hours to your day.
23,599 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
A 72-year-old returns to work after medical bills and rising living costs erode his Social Security, highlighting ris...
Federal health officials warn of potential listeria in Wellsley Farms Atlantic salmon sold at BJ’s Wholesale Club. Th...
A major investment manager recently disclosed a sizable position in Varonis Systems. This article unpacks what the mo...
Two parallel paths are emerging in legal AI: one focused on enterprise rigor and governance, the other on broad, open...
A governance gap in autonomous AI agents threatens personal finances as firms rush AI adoption. Experts warn that unc...
A bloc of 16 attorneys general filed a federal lawsuit against HUD, saying guidance to FHAP agencies could decertify ...
With whispers of funded shortfalls, retirees social security just may face tighter benefits. This guide breaks down w...
May often stirs market chatter about seasonal weakness, yet patient investors can find lasting value. Here are two gr...
Gen Z entrepreneurs are using AI tools to launch startups faster. A new industry report highlights AI’s growing role ...
A new international ETF pairs overseas blue chips with a covered-call strategy to generate monthly distributions and ...
Marvell Technology shares surprised investors with a notable intraday uptick amid improving sentiment for semiconduct...